"But don’t they end up looking even sillier trying to sneak the information through into an SEC filing on a Friday evening?"
I don't think that any serious analyst, other than yourself, would seek this out.
I don't know the company other than in passing, but the idea of a baby bio going after the depilatory market seemed like a headline grabber more than anything else. That market is commoditized - I just don't see the markups necessary for a biotech to make its money. Not many HMOs willing to pay big bucks for prescription hair removal 8-)
Regards,
Bob
Market Data 
Markets 
AI
